SR-X Biomarker Detectio System Maintenance Services

The National Institute of Child Health and Human Development (NICHD) at the National Institutes of Health is soliciting maintenance services for the Quanterix SR-X Biomarker Detection System (Model SR-X 2042QP0546) and an associated Washer (Model PW-2021038) located at the Clinical Research Center in Bethesda, Maryland. This procurement falls under NAICS Code 811210 (Electronic and Precision Equipment Repair and Maintenance) and PSC Code J066 (Maintenance, Repair, and Rebuilding of Laboratory Equipment). The solicitation intends to award a purchase order directly to Quanterix of Billerica, Massachusetts, as the original equipment manufacturer, to ensure warranty protection and minimize service disruption risks that would result from third-party maintenance. Vendors must submit quotations by December 20, 2025, at 12:00 PM via email to Kelly Robinson, and must include their Unique Entity Identifier (UEI), Taxpayer Identification Number (TIN), and business size certification. The evaluation criteria prioritize maintaining manufacturer warranty coverage and minimizing operational disruption to the Clinical Research Center's laboratory operations.

This procurement is unrestricted and includes no set-aside designation for small businesses. Quanterix Corporation is the anticipated incumbent and sole-source contractor based on their status as the original equipment manufacturer. The contract covers one-year warranty extensions for the specified equipment, with an initial period of performance from January 14, 2026, to January 13, 2027, and includes one option year extending from January 14, 2027, to January 13, 2028. No specific budget range is disclosed in the pre-solicitation materials, though the business size standard for this NAICS code is $34,000,000. The solicitation requires vendors to provide comprehensive quotations for the warranty extension services, with the understanding that direct award to Quanterix maintains critical laboratory functionality and protects the government's investment in the specialized biomarker detection equipment.